Curis Inc. – Credit Agreements

NASDAQ: CRIS
Share price (9/18/26): $1.00
Market cap (9/18/26): $2.090 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Credit Agreements Filter

from 10-K 79 pages Confidential Materials Omitted and Filed Separately With the Securities and Exchange Commission. Double Asterisks Denote Omissions. Credit Agreement Dated as of March 6, 2017

from 10-K 81 pages Confidential Materials Omitted and Filed Separately With the Securities and Exchange Commission. Double Asterisks Denote Omissions. Credit Agreement Dated as of November 27, 2012 Among Curis Royalty LLC, as Borrower, Biopharma Secured Debt Fund II Sub, S. À R. L., as Lender, and Curis, Inc., as Parent Credit Agreement Dated as of November 27, 2012

from 8-K 3 pages Secured Non-Revolving Time Note

from 8-K 9 pages Line of Credit Agreement for the Acquisition of Equipment and Leasehold Improvements ($1,450,000.00 Line) June 9, 2005

from 10-K 3 pages Secured Non-Revolving Time Note

from 10-K 10 pages Line of Credit Agreement for the Acquisition of Equipment and Leasehold Improvements ($2,250,000.00 Line) September 23, 2004

from 10-K 3 pages Secured Non-Revolving Time Note

from 10-K 9 pages Line of Credit Agreement for the Acquisition of Equipment and Leasehold Improvements

from 10-Q 13 pages “Section 1 Amount and Terms of Credit and Interest the Revolving Loan

from 8-K ~10 pages Loan Agreement Dated June 14, 2002